BMY
BMY
NYSE · Pharmaceuticals

Bristol-Myers Squibb Co

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$55.53
+0.83 (+1.52%)
As of Jun 23, 9:31 PM ET ·
Analyst Consensus
Hold
36
Analysts
Very High
Coverage
Buy 14 39%
Hold 20 56%
Sell 2 6%
Price Target
Analyst Price Target +214.2% upside
Low Target $130.78
Average Target $174.50
High Target $195.10
Current Price $55.53
Current
$55.53
Target
$174.50
$130.78 $174.50 avg $195.10
Scenario Analysis
Bear Case
$130.78
135.5%
Low target
Base Case
$174.50
+214.2%
Avg target
Bull Case
$195.10
+251.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$62.89
-11.7% from high
52-Week Low
$42.52
+30.6% from low
50-Day SMA
$55.66
-0.2% vs SMA
200-Day SMA
$49.00
+13.3% vs SMA
RSI (14)
74.1
Overbought
Target vs 52W High
$174.50
+177.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
 Sell 44 50% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
 Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
 Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
 Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
 Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -34.5%